Godrej Agrovet Ltd

CDPL is one of the leading private dairy companies in southern India and its products are sold under the brand name 'Godrej Jersey'. Its turnover was Rs 1,540.50 crore in FY24. The rational for the acquisition is to convert CDPL into a wholly owned subsidiary by acquiring remaining 48.06% equity stake from the existing equity shareholders of CDPL, in order to consolidate the company's position in CDPL. Pre acquisition, the company held 58,81,508 shares (51.94%), whereas post acquisition, it will hold 1,13,24,700 equity shares (100%) in CDPL. The said transaction is expected to be completed on or before 30 September 2025. Meanwhile, the company's board approved the appointment of and remuneration payable to Y. V. Sathish as head ' manufacturing & supply chain excellence effective from March 24, 2025. Y. V. Sathish brings nearly three decades of extensive experience across geographies and diverse cultures, having worked with renowned FMCG companies like GlaxoSmithKline and Hindustan Unilever. Godrej Agrovet is an agri-business company in India that focuses on research and development to improve the productivity of Indian farmers. It offers a range of products and services to increase crop and livestock yields sustainably. The company is a leader in various sectors, including animal feed, crop protection, oil palm, dairy, poultry, and processed foods. The company's consolidated net profit jumped 21.4% to Rs 111.49 crore in Q3 FY25 as compared with Rs 91.84 crore in same quarter last year. Net sales increased 4.4% YoY to Rs 2,444.64 crore during the quarter ended 31st December 2024. Powered by Capital Market - Live

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the appointment of Y. V. Sathish as 'Head' Manufacturing & Supply Chain Excellence' of the company effective from 24 March 2025. Powered by Capital Market - Live

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the acquisition of balance 48.06% equity stake in Creamline Dairy Products (CDPL), making CDPL a wholly owned subsidiary of the Company, upon completion of the said acquisition. Powered by Capital Market - Live

The board of Godrej Agrovet at its meeting held on 11 February 2025 has approved the appointment and remuneration of Sunil Kataria (DIN: 06863609) as the 'Chief Executive Officer & Managing Director - Designate' of the Company for a period commencing from 05 May 2025 upto 31 August 2025 and subsequently after superannuation of Balram Singh Yadav, as 'Chief Executive Officer & Managing Director', for a term of 5 (Five) Years commencing from 01 September 2025 upto 31 August 2030, subject to the approval of the ShareholderPowered by Capital Market - Live

Net profit of Godrej Agrovet rose 21.40% to Rs 111.49 crore in the quarter ended December 2024 as against Rs 91.84 crore during the previous quarter ended December 2023. Sales rose 4.39% to Rs 2444.64 crore in the quarter ended December 2024 as against Rs 2341.87 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales2444.642341.87 4 OPM %9.006.79 - PBDT207.96155.02 34 PBT151.25102.01 48 NP111.4991.84 21 Powered by Capital Market - Live

Godrej Agrovet will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live

Godrej Agrovet's Animal Feed business is launching 'Godrej Pride Hog', a scientifically developed Pig Feed range designed to provide optimal nutrition at each stage of a pig's lifecycle. Powered by Capital Market - Live

Profit before tax for Q2 FY25 increased to Rs 149.90 crore, up 6.49% from Rs 140.76 crore in Q2 FY24. During the quarter, the consolidated EBITDA jumped to Rs 221 crore, registering a growth of 2.9% as compared to Rs 215 crore reported in Q2 FY25. EBITDA margin improved to 9% in the September quarter as against 8.3% recorded in the corresponding quarter previous year. In the animal feed category, the company witnessed marginal de-growth in volumes primarily on account of lower volumes in cattle feed due to lower milk prices. Layer and broiler feed volumes grew sequentially by 21.6% & 2.0% respectively and improved y-o-y by 10.8% & 5.5%, respectively. In the vegetable oil segment, higher realizations in both Crude Palm Oil (CPO) & Palm Kernel Oil (PKO), improved Oil Extraction Ratio (OER) & downstream value added products improved profitability in Q2 FY25 y-o-y. Astec LifeSciences' Topline & profitability was marred by lower realizations in key enterprise products coupled with lower-than-expected volumes in CDMO segment due to cautious approach adopted by CDMO customers. The dairy business Segment revenue was flat y-o-y due to volumes remaining at similar levels. Godrej Tyson Foods revenues declined in Q2 FY25 as compared to Q2 FY24, primarily due to lower volumes in live bird business as GTFL continued to focus on branded business & reduce exposure to live bird business. ACI Godrej Agrovet posted revenue de-growth of 6% year-on-year (in local currency terms) in Q2 FY25 due to economic headwinds in Bangladesh amidst political turmoil and severe floods. B. S. Yadav, managing director, Godrej Agrovet, said, 'Godrej Agrovet continued to deliver robust improvement in profitability with the exception of Astec LifeSciences and Poultry business. EBITDA margins (excluding non-recurring items) improved in Q2 FY25 by around 70 bps and approximately 130 bps excluding Astec as compared to Q2 FY24. All the segments, with the exception of Astec LifeSciences and the Poultry business achieved growth in profitability. Domestic Crop Protection business achieved a significant improvement in segment margins, primarily due to lower doubtful debts & control over fixed costs. Topline declined compared to the previous year due to erratic rainfall across key states which resulted in reduction in spraying opportunities in herbicides category. Animal Feed business also witnessed a remarkable improvement in segment margins due to favorable commodity positions & cost optimization measures. However, the overall volume growth was impacted by subdued growth in cattle feed due to lower milk prices, while the Layer and Broiler feed grew y-o-y & sequentially. Dairy business continued its upward trajectory, with profitability significantly improving compared to Q2 FY24. Consistent operational efficiency improvements and favorable milk spread contributed to this improved performance. In the Vegetable Oil business, higher realizations in respect of end products coupled with an improved Oil Extraction Ratio (OER) led to enhanced segment margins in Q2 FY25 compared to same period previous year, despite lower FFB arrivals. Astec LifeSciences topline & profitability was severely impacted due lower realizations in key enterprise products coupled with lower-than-expected volumes in CDMO segment due to cautious approach adopted by CDMO customers. However, gradual uptick in demand resulted in sequential improvement in performance.' Godrej Agrovet is an agri-business company in India that focuses on research and development to improve the productivity of Indian farmers. It offers a range of products and services to increase crop and livestock yields sustainably. The company is a leader in various sectors, including animal feed, crop protection, oil palm, dairy, poultry, and processed foods.Powered by Capital Market - Live

Net profit of Godrej Agrovet rose 6.57% to Rs 112.30 crore in the quarter ended September 2024 as against Rs 105.38 crore during the previous quarter ended September 2023. Sales declined 4.83% to Rs 2442.68 crore in the quarter ended September 2024 as against Rs 2566.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2442.682566.71 -5 OPM %9.147.85 - PBDT208.24193.65 8 PBT149.90140.76 6 NP112.30105.38 7 Powered by Capital Market - Live

Godrej Agrovet will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live